111 related articles for article (PubMed ID: 19233606)
21. [Wilson Disease].
Rev Prat; 2014 Apr; 64(4):564. PubMed ID: 24855798
[No Abstract] [Full Text] [Related]
22. Wilson disease: a matter of copper, but also of zinc.
Iorio R; Ranucci G
J Pediatr Gastroenterol Nutr; 2015 Apr; 60(4):423-4. PubMed ID: 25611032
[No Abstract] [Full Text] [Related]
23. [WILSON-KONOVALOV'S DISEASE IN TWO SISTERS: DIFFERENCES IN THE CLINICAL PICTURE AND SUCCESSFUL THERAPY].
Ignatova TM; Solov'eva O V ; Arion EA; Balashova MS; Rozina TP
Klin Med (Mosk); 2016; 94(1):70-3. PubMed ID: 27172728
[TBL] [Abstract][Full Text] [Related]
24. Wilson disease: a most unusual patient.
Walshe JM
QJM; 2016 Feb; 109(2):117-8. PubMed ID: 26286547
[No Abstract] [Full Text] [Related]
25. Diagnosis and treatment of Wilson disease: an update.
Roberts EA; Schilsky ML;
Hepatology; 2008 Jun; 47(6):2089-111. PubMed ID: 18506894
[No Abstract] [Full Text] [Related]
26. [Copper transport and associated genetic disorders].
Wu JJ; Jiang YP
Sheng Li Ke Xue Jin Zhan; 2000 Oct; 31(4):341-4. PubMed ID: 11372428
[No Abstract] [Full Text] [Related]
27. [Therapy of Wilson disease].
Smolarek C; Stremmel W
Z Gastroenterol; 1999 Apr; 37(4):293-300. PubMed ID: 10378366
[TBL] [Abstract][Full Text] [Related]
28. 50 Years Ago in The Journal of Pediatrics: hepatolenticular degeneration: observations on a case treated with D-penicillamine.
Choquette M
J Pediatr; 2013 Oct; 163(4):1079. PubMed ID: 24070537
[No Abstract] [Full Text] [Related]
29. Copper and liver disease.
Danks DM
Eur J Pediatr; 1991 Jan; 150(3):142-8. PubMed ID: 2044580
[TBL] [Abstract][Full Text] [Related]
30. Teaching Video NeuroImages: Myoclonus as the presenting feature of Wilson disease.
Kumar N; Kumar D
Neurology; 2019 Apr; 92(14):e1667-e1668. PubMed ID: 30936238
[No Abstract] [Full Text] [Related]
31. Polymorphism of methylenetetrahydrofolate reductase as disease modifier - a déjà-vu in Wilson disease?
Ferenci P
J Hepatol; 2011 Oct; 55(4):753-5. PubMed ID: 21396415
[No Abstract] [Full Text] [Related]
32. A copper for your thoughts.
Coates RA
J Insur Med; 2012; 43(2):112-5. PubMed ID: 22876415
[No Abstract] [Full Text] [Related]
33. Long-term exclusive zinc monotherapy in symptomatic Wilson disease: experience in 17 patients.
Linn FH; Houwen RH; van Hattum J; van der Kleij S; van Erpecum KJ
Hepatology; 2009 Nov; 50(5):1442-52. PubMed ID: 19731238
[TBL] [Abstract][Full Text] [Related]
34. Neurological Wilson's disease lethal for the son, asymptomatic in the father.
Denoyer Y; Woimant F; Bost M; Edan G; Drapier S
Mov Disord; 2013 Mar; 28(3):402-3. PubMed ID: 23389864
[No Abstract] [Full Text] [Related]
35. Wilson disease--a practical approach to diagnosis, treatment and follow-up.
Medici V; Rossaro L; Sturniolo GC
Dig Liver Dis; 2007 Jul; 39(7):601-9. PubMed ID: 17382611
[TBL] [Abstract][Full Text] [Related]
36. Effect of D-penicillamine on liver fibrosis and inflammation in Wilson disease.
Kazemi K; Geramizadeh B; Nikeghbalian S; Salahi H; Bahador A; Reza Nejatollahi SM; Dehghani SM; Dehghani M; Kakaei F; Malek-Hosseini SA
Exp Clin Transplant; 2008 Dec; 6(4):261-3. PubMed ID: 19338486
[TBL] [Abstract][Full Text] [Related]
37. Wilson disease - currently used anticopper therapy.
Członkowska A; Litwin T
Handb Clin Neurol; 2017; 142():181-191. PubMed ID: 28433101
[TBL] [Abstract][Full Text] [Related]
38. [Diagnosis and care of Wilson disease with neurological revelation].
Wagner S; Brunet AS; Bost M; Lachaux A; Broussolle E; Des Portes V; Lion-François L
Arch Pediatr; 2012 Mar; 19(3):271-6. PubMed ID: 22261259
[TBL] [Abstract][Full Text] [Related]
39. [Pathogenesis and treatment of Wilson's disease].
Nagy J; Vincze Z; Folhoffer A; Horváth A; Csák T; Zelkó R
Acta Pharm Hung; 2003; 73(4):237-41. PubMed ID: 15279036
[TBL] [Abstract][Full Text] [Related]
40. [Clinical character and therapeutic effect of late-onset Wilson disease].
Zhang Y; Yang X; Tang X; Luo H; Lei J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2009 Jan; 34(1):40-4. PubMed ID: 19197125
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
